Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

15.5K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.5K
Ligand Binding Sites02:40

Ligand Binding Sites

9.0K
9.0K
Conserved Binding Sites01:49

Conserved Binding Sites

5.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

5.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Noncovalent Small-Molecules from Virtual Screening Toward the Development of Potential KRAS Inhibitors.

Journal of chemical information and modeling·2026
Same author

Synthesis and Biochemical Characterization of Investigational Pyrazolopyrimidine-Based Allosteric KRAS Modulators.

ACS medicinal chemistry letters·2026
Same author

MRTX1133 Suppresses ERK Signaling but Elicits Context-Dependent Antiproliferative Responses in KRAS (G12C) Cancer Cells.

Molecular cancer therapeutics·2026
Same author

MRTX1133 suppresses ERK signaling but elicits context-dependent antiproliferative responses in KRAS (G12C) cancer cells.

Molecular cancer therapeutics·2026
Same author

RAS-membrane interaction and oligomerization: there is more than meets the eye.

Biochemical Society transactions·2025
Same author

BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injury.

Nature·2025

Related Experiment Video

Updated: Mar 6, 2026

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

2.2K

Mixed-Probe Simulation and Probe-Derived Surface Topography Map Analysis for Ligand Binding Site Identification.

Abdallah Sayyed-Ahmad1, Alemayehu A Gorfe1

  • 1Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston , 6431 Fannin Street, Houston, Texas 77030, United States.

Journal of Chemical Theory and Computation
|March 3, 2017
PubMed
Summary

This study enhances pMD-membrane, a computational method for identifying drug targets on membrane proteins. The improved technique accurately maps ligand binding sites and surface features, aiding drug discovery for oncogenic K-Ras mutants.

More Related Videos

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
07:33

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry

Published on: October 15, 2018

15.1K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.2K

Related Experiment Videos

Last Updated: Mar 6, 2026

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

2.2K
Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
07:33

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry

Published on: October 15, 2018

15.1K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.2K

Area of Science:

  • Computational chemistry
  • Structural biology
  • Pharmacology

Background:

  • Membrane proteins are crucial pharmaceutical drug targets.
  • Identifying ligand binding pockets computationally is essential for drug discovery.
  • pMD-membrane is a probe-based molecular dynamics simulation technique for detecting binding sites on membrane proteins.

Purpose of the Study:

  • To extend the pMD-membrane technique with diverse cosolvents.
  • To develop new analysis tools for quantifying probe densities and generating surface topography maps.
  • To explore the druggability of oncogenic K-Ras mutants using the enhanced pMD-membrane approach.

Main Methods:

  • Utilized probe-based molecular dynamics simulations with small organic cosolvents.
  • Developed a projection technique for quantifying global probe densities on protein surfaces.
  • Introduced a surface topography mapping technique based on probe-binding propensity.
  • Applied the extended pMD-membrane to analyze K-Ras mutants (G12D, G12V, G13D) in a lipid bilayer.

Main Results:

  • The enhanced pMD-membrane robustly identified known allosteric ligand binding sites on K-Ras mutants.
  • New analysis tools effectively mapped surface topography and filtered relevant hotspots.
  • Differential membrane interactions were shown to modulate pocket accessibility.

Conclusions:

  • The extended pMD-membrane and analysis tools provide a powerful approach for exploring membrane protein druggability.
  • The method successfully identified key binding sites and surface features on oncogenic K-Ras mutants.
  • This computational strategy aids in understanding protein-ligand interactions and facilitates drug development for membrane protein targets.